Figure 5.
The average number of trials to criterion for males and females during the DSST. Measures of the average number of trials to criterion at baseline (prior to treatment with ketamine) at each stage of the DSST consisting of the VCT, FLT, FLT-reversal, VCDT and ACDT, *p<0.05 (n=42 females, n=42 males).